메뉴 건너뛰기




Volumn 20, Issue 1, 2015, Pages 49-55

Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor

Author keywords

[No Author keywords available]

Indexed keywords

LANINAMIVIR; OSELTAMIVIR; PERAMIVIR; SIALIDASE INHIBITOR; ANTIVIRUS AGENT; CYCLOPENTANE DERIVATIVE; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; SIALIDASE; VIRUS PROTEIN; ZANAMIVIR;

EID: 84927752470     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2798     Document Type: Article
Times cited : (14)

References (24)
  • 1
    • 80052935987 scopus 로고    scopus 로고
    • Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children
    • Sugaya N, Shinjoh M, Mitamura K, Takahashi T. Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: analysis of 1000 hospitalized children. J Infect 2011; 63:288-294.
    • (2011) J Infect , vol.63 , pp. 288-294
    • Sugaya, N.1    Shinjoh, M.2    Mitamura, K.3    Takahashi, T.4
  • 2
    • 84856301088 scopus 로고    scopus 로고
    • Pandemic (H1N1) 2009 in pregnant Japanese women in hokkaido
    • Yamada T, Morikawa M, Cho K, et al. Pandemic (H1N1) 2009 in pregnant Japanese women in Hokkaido. J Obstet Gynaecol Res 2012; 38:130-136.
    • (2012) J Obstet Gynaecol Res , vol.38 , pp. 130-136
    • Yamada, T.1    Morikawa, M.2    Cho, K.3
  • 3
    • 84455192539 scopus 로고    scopus 로고
    • Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection
    • Sugaya N, Kohno S, Ishibashi T, Wajima T, Takahashi T. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection. Antimicrob Agents Chemother 2012; 56:369-377.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 369-377
    • Sugaya, N.1    Kohno, S.2    Ishibashi, T.3    Wajima, T.4    Takahashi, T.5
  • 4
    • 79956299861 scopus 로고    scopus 로고
    • Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients
    • Kohno S, Kida H, Mizuguchi M, et al. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother 2011; 55:2803-2812.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 2803-2812
    • Kohno, S.1    Kida, H.2    Mizuguchi, M.3
  • 5
    • 77952611625 scopus 로고    scopus 로고
    • Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection
    • Sugaya N, Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob Agents Chemother 2010; 54:2575-2582.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 2575-2582
    • Sugaya, N.1    Ohashi, Y.2
  • 6
    • 78349241129 scopus 로고    scopus 로고
    • Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial
    • Watanabe A, Chang SC, Kim MJ, Chu DW, Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: a double-blind, randomized, noninferiority clinical trial. Clin Infect Dis 2010; 51:1167-1175.
    • (2010) Clin Infect Dis , vol.51 , pp. 1167-1175
    • Watanabe, A.1    Chang, S.C.2    Kim, M.J.3    Chu, D.W.4    Ohashi, Y.5
  • 7
    • 84855436488 scopus 로고    scopus 로고
    • Widespread use of neuraminidase inhibitors in Japan
    • Sugaya N. Widespread use of neuraminidase inhibitors in Japan. J Infect Chemother 2011; 17:595-601.
    • (2011) J Infect Chemother , vol.17 , pp. 595-601
    • Sugaya, N.1
  • 8
    • 0032005791 scopus 로고    scopus 로고
    • Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense
    • Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998; 101:643-649.
    • (1998) J Clin Invest , vol.101 , pp. 643-649
    • Hayden, F.G.1    Fritz, R.2    Lobo, M.C.3    Alvord, W.4    Strober, W.5    Straus, S.E.6
  • 9
    • 77957330450 scopus 로고    scopus 로고
    • Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: Opportunistic retrospective study of medical charts in China
    • Yu H, Liao Q, Yuan Y, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010; 341:c4779.
    • (2010) BMJ , vol.341
    • Yu, H.1    Liao, Q.2    Yuan, Y.3
  • 10
    • 84863321543 scopus 로고    scopus 로고
    • Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: A comparison with seasonal H1N1 with or without H275Y mutation
    • Kawai N, Ikematsu H, Iwaki N, et al. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation. J Infect Chemother 2012; 18:180-186.
    • (2012) J Infect Chemother , vol.18 , pp. 180-186
    • Kawai, N.1    Ikematsu, H.2    Iwaki, N.3
  • 11
    • 78649537402 scopus 로고    scopus 로고
    • Duration of viral shedding in patients admitted to hospital with pandemic inflluenza A/H1N1 2009 infection
    • Na S, Chong YP, Kim MN, et al. Duration of viral shedding in patients admitted to hospital with pandemic inflluenza A/H1N1 2009 infection. J Med Virol 2011; 83:5-9.
    • (2011) J Med Virol , vol.83 , pp. 5-9
    • Na, S.1    Chong, Y.P.2    Kim, M.N.3
  • 12
    • 77749308310 scopus 로고    scopus 로고
    • Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection
    • Ling LM, Chow AL, Lye DC, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010; 50:963-969.
    • (2010) Clin Infect Dis , vol.50 , pp. 963-969
    • Ling, L.M.1    Chow, A.L.2    Lye, D.C.3
  • 13
    • 84859099036 scopus 로고    scopus 로고
    • Viral shedding of 2009 pandemic H1N1 and evaluation of quarantine recommendations
    • Chin BS, Chae YT, Choi HK, et al. Viral shedding of 2009 pandemic H1N1 and evaluation of quarantine recommendations. Jpn J Infect Dis 2012; 65:105-110.
    • (2012) Jpn J Infect Dis , vol.65 , pp. 105-110
    • Chin, B.S.1    Chae, Y.T.2    Choi, H.K.3
  • 14
    • 33846138361 scopus 로고    scopus 로고
    • Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children
    • Sugaya N, Mitamura K, Yamazaki M, et al. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis 2007; 44:197-202.
    • (2007) Clin Infect Dis , vol.44 , pp. 197-202
    • Sugaya, N.1    Mitamura, K.2    Yamazaki, M.3
  • 15
    • 23744452330 scopus 로고    scopus 로고
    • Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor
    • Hatakeyama S, Sakai-Tagawa Y, Kiso M, et al. Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol 2005; 43:4139-4146.
    • (2005) J Clin Microbiol , vol.43 , pp. 4139-4146
    • Hatakeyama, S.1    Sakai-Tagawa, Y.2    Kiso, M.3
  • 16
    • 77955093550 scopus 로고    scopus 로고
    • Differentiation of human influenza A viruses including the pandemic subtype H1N1/2009 by conventional multiplex PCR
    • Furuse Y, Odagiri T, Okada T, et al. Differentiation of human influenza A viruses including the pandemic subtype H1N1/2009 by conventional multiplex PCR. J Virol Methods 2010; 168:94-97.
    • (2010) J Virol Methods , vol.168 , pp. 94-97
    • Furuse, Y.1    Odagiri, T.2    Okada, T.3
  • 17
    • 2642574503 scopus 로고    scopus 로고
    • (Accessed 7 December 2013.) Available from
    • The R Project for Statistical Computing. A language and environment for statistical computing, 2012. (Accessed 7 December 2013.) Available from http://www.R-project.org/.
    • (2012) A Language and Environment for Statistical Computing
  • 18
    • 4444369826 scopus 로고    scopus 로고
    • Resistant influenza A viruses in children treated with oseltamivir: Descriptive study
    • Kiso M, Mitamura K, Sakai-Tagawa Y, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004; 364:759-765.
    • (2004) Lancet , vol.364 , pp. 759-765
    • Kiso, M.1    Mitamura, K.2    Sakai-Tagawa, Y.3
  • 19
    • 77955116713 scopus 로고    scopus 로고
    • Update: Influenza activity - United states, 2009-10 season
    • Centers for Disease Control and Prevention. Update: influenza activity - United States, 2009-10 season. MMWR Morb Mortal Wkly Rep 2010; 59:901-908.
    • (2010) MMWR Morb Mortal Wkly Rep , vol.59 , pp. 901-908
  • 20
    • 78650853324 scopus 로고    scopus 로고
    • Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an his275tyr genotyping assay using the cycling probe method
    • Suzuki Y, Saito R, Sato I, et al. Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method. J Clin Microbiol 2011; 49:125-130.
    • (2011) J Clin Microbiol , vol.49 , pp. 125-130
    • Suzuki, Y.1    Saito, R.2    Sato, I.3
  • 21
    • 84867554833 scopus 로고    scopus 로고
    • Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09
    • Louie JK, Yang S, Acosta M, et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis 2012; 55:1198-1204.
    • (2012) Clin Infect Dis , vol.55 , pp. 1198-1204
    • Louie, J.K.1    Yang, S.2    Acosta, M.3
  • 22
    • 84873697558 scopus 로고    scopus 로고
    • Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: A systematic review and meta-analysis in hospitalized patients
    • Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013; 207:553-563.
    • (2013) J Infect Dis , vol.207 , pp. 553-563
    • Muthuri, S.G.1    Myles, P.R.2    Venkatesan, S.3    Leonardi-Bee, J.4    Nguyen-Van-Tam, J.S.5
  • 23
    • 84880423578 scopus 로고    scopus 로고
    • Clinical effectiveness of neuraminidase inhibitors-oseltamivir, zanamivir, laninamivir, and peramivir-for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: An observational study in the 2010-2011 influenza season in Japan
    • Shobugawa Y, Saito R, Sato I, et al. Clinical effectiveness of neuraminidase inhibitors-oseltamivir, zanamivir, laninamivir, and peramivir-for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan. J Infect Chemother 2012; 18:858-864.
    • (2012) J Infect Chemother , vol.18 , pp. 858-864
    • Shobugawa, Y.1    Saito, R.2    Sato, I.3
  • 24
    • 47549100591 scopus 로고    scopus 로고
    • Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children
    • Sugaya N, Tamura D, Yamazaki M, et al. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children. Clin Infect Dis 2008; 47:339-345.
    • (2008) Clin Infect Dis , vol.47 , pp. 339-345
    • Sugaya, N.1    Tamura, D.2    Yamazaki, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.